Newer devices incorporate advanced algorithms to have more accurate delivery of implantable cardioverter-defibrillator (ICD) therapy. Newer models of Abbott Implantable cardioverter-defibrillators like Gallant and Entrant have a new ventricular fibrillation (VF) therapy assurance algorithm. This algorithm has a proven role in avoiding under-detection of VF where some of the smaller electrograms are under-sensed.
View Article and Find Full Text PDFIndian Pacing Electrophysiol J
September 2022
A 63-year-old lady with a high-grade atrioventricular (AV) block and a structurally normal heart underwent permanent pacemaker implantation (dual chamber, Medtronic Ltd) 8 years back. On follow up, she had a recurrence of syncope after 3 years. The device interrogation at that time had revealed ventricular tachycardia (VT) for which she underwent implantable cardioverter defibrillator (ICD, Medtronic Ltd, Egida DR, DF1) upgradation at another center (electrograms not available).
View Article and Find Full Text PDF